Status:

ACTIVE_NOT_RECRUITING

A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Lead Sponsor:

Eli Lilly and Company

Conditions:

Juvenile Psoriatic Arthritis

Enthesitis Related Arthritis

Eligibility:

All Genders

2-17 years

Phase:

PHASE3

Brief Summary

The reason for this study is to see if the study drug ixekizumab is safe and effective in children with juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) (including ...

Eligibility Criteria

Inclusion

  • Participants must have active juvenile idiopathic arthritis (categories of enthesitis related arthritis or juvenile psoriatic arthritis)
  • Participants must have weight of at least 10 kilograms (Kg), age starting at 2 years for participants with juvenile psoriatic arthritis and starting at 6 years for participants with enthesitis related arthritis
  • Participants must have all immunizations up-to-date in agreement with current immunization guidelines, in the opinion of the investigator

Exclusion

  • Participants must not have active or history of inflammatory bowel disease
  • Participants must not have active uveitis
  • Participants must not have active or latent tuberculosis
  • Participants must not have an active infection
  • Participants must not have concurrent use of biologic agents for the treatment of the juvenile idiopathic arthritis

Key Trial Info

Start Date :

April 13 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2028

Estimated Enrollment :

101 Patients enrolled

Trial Details

Trial ID

NCT04527380

Start Date

April 13 2021

End Date

April 1 2028

Last Update

June 5 2025

Active Locations (43)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 11 (43 locations)

1

Instituto CAICI SRL Loc. 15

Rosario, Santa Fe Province, Argentina, S2000

2

Centro Medico Privado de Reumatologia Loc. 20

San Miguel de Tucumán, Tucumán Province, Argentina, T4000AXL

3

Cliniques universitaires Saint-Luc

Brussels, Bruxelles-Capitale, Région de, Belgium, 1200

4

UZ Gent

Ghent, Oost-Vlaanderen, Belgium, 9000